NCT01887821View on ClinicalTrials.gov

Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam

PHASE4CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Plasmodium Vivax Malaria
Interventions
DRUG

Chloroquine

DRUG

Dihydroartemisinin/Piperaquine

Trial Locations (1)

Unknown

Bu Gia Map Health Station, Phước Hòa

Sponsors
All Listed Sponsors
collaborator

Institute of Malaria, Parasitology and Entomology, Ho Chi Minh City, Viet Nam

UNKNOWN

collaborator

Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

OTHER

collaborator

Agency for Science, Technology and Research

OTHER

collaborator

Wellcome Trust

OTHER

lead

Oxford University Clinical Research Unit, Vietnam

OTHER